Having trouble viewing this email? Click here.
 
A SPECIAL
ANNOUNCEMENT FROM:
  BioPharm Logo  
 

As upstream expression increases bioreactor titers, downstream WFI water usage increases proportionally. This places increased throughput pressure on downstream’s existing plant tankage for buffer prep, buffer storage, and in-process product hold steps.

TOYOPEARL GigaCap® CM-650M resin reduces target elution volumes up to 75%. By maintaining its 100 g mAb/L dynamic binding capacity in loading conductivities up to 11 mS/cm (pH 4.7), TOYOPEARL GigaCap CM-650M resin can also minimize the amount of water needed for feedstock dilution.

The bottom line is that TOYOPEARL GigaCap CM-650M resin, when placed early in the chromatographic purification train, can reduce the amount of WFI water used in subsequent manufacturing steps.


Buffer conductivity effect on TOYOPEARL GigaCap CM-650M capacity (polyclonal h-IgG):

Feel free to email me if you have any questions or would like to request a sample.

Cordially,

Al Jackewitz
Biopurification Market Manager

3604 Horizon Drive, Suite 100
King of Prussia, PA 19406
ph:800-366-4875 fax:610-272-3028
www.tosohbioscience.com

Tosoh Bioscience and TOYOPEARL GigaCap are registered trademarks of Tosoh Corporation.


 

If you no longer wish to receive TOSOH BIOSCIENCE mailings, please Click Here.

BioPharm International
is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.

 

 

Brochure whitepaper Application Notes Downloads